Qnovia has secured the funding to take its lead inhaled drug delivery candidate into the clinic, rounding up $17 million in series A funding to start testing its nicotine replacement therapy (NRT) in ...

LAUSANNE, Switzerland--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage ...

With $35 million in funding, Qnovia hopes its device will become the first new prescription nicotine replacement therapy in 20 years. Six years ago, in a townhouse in Santa Monica, Mario Danek, began ...

BOONE, N.C.--(BUSINESS WIRE)--Pneuma Respiratory, a med-tech and pharmaceutical company dedicated to advancing inhaled respiratory therapeutics, is introducing new transformational approaches to ...

LONDON (Reuters) -A handful of North American companies which see potential for vape-like devices to ease migraines and respiratory diseases such as asthma have a long road to convince health ...

Philip Morris International Inc. PM has been firm on its ambitious plans to expand "Beyond Nicotine" products. Along these lines, the company announced the acquisition of OtiTopic, a respiratory drug ...

Nicotine itself is bad news for blood vessels. In A Nutshell All nicotine products damage your heart and blood vessels, ...

It's tough to quit smoking and many people opt for substitutes like nicotine patches or gum to make the transition easier. But does that mean you're picking up another addiction? According to health ...

Please provide your email address to receive an email when new articles are posted on . Use of e-cigarettes that contain nicotine may cause an immediate increase in blood clot formation and ...

One day, long ago, a tobacco plant discovered humans and it has never relinquished its control over our brain. During the intervening millennia, we humans have tried to find novel uses for this plant ...